Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;19(Suppl 3):S37-44.
doi: 10.3747/co.19.1287.

Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret

J J Aning  1 , R J Wassersug, S L Goldenberg
Affiliations

Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret

J J Aning et al. Curr Oncol. 2012 Dec.

Abstract

The number of prostate cancer survivors is rapidly growing in the Western world. As a result of better oncologic outcomes, more patients are living longer with the adverse effects of treatment, which can be both functional and psychological. Clinicians, in an era of shared decision-making, must not only cure the cancer, but also ensure that, after treatment, their patients experience the best quality of life and minimal post-treatment decisional regret. To participate in the decision-making process, men and their involved partners and family need to fully understand the relative benefits and harms of prostate cancer treatments.Patient preference studies indicate that men with prostate cancer are not well informed. Decision-making aids are a positive treatment adjunct both to convey information and to allow patients to explore their own beliefs and values during the decision-making process. The evidence suggests that decision-making aids better prepare patients for involvement in treatment decisions, but further studies are required to investigate the relationship between the use of decision-making aids and post-treatment decisional regret in prostate cancer.

Keywords: Prostate cancer; decision-making aids; decisional regret; partners; patient preferences.

PubMed Disclaimer

References

    1. Canadian Cancer Society’s Steering Committee on Cancer Statistics . Canadian Cancer Statistics 2012. Toronto, ON: Canadian Cancer Society; 2012. [Available online at: http://www.cancer.ca/Canada-wide/About%20cancer/~/media/CCS/Canada%20wid...; cited September 19, 2012]
    1. Eggener SE, Scardino PT, Walsh PC, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011;185:869–75. doi: 10.1016/j.juro.2010.10.057. - DOI - PMC - PubMed
    1. Warde P, Mason M, Ding K, et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet. 2011;378:2104–11. doi: 10.1016/S0140-6736(11)61095-7. - DOI - PMC - PubMed
    1. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28:126–31. doi: 10.1200/JCO.2009.24.2180. - DOI - PubMed
    1. de Bono JS, Logothetis CJ, Molina A, et al. Abiraterone and increased survival in metastatic prostate cancer. N Eng J Med. 2011;364:1995–2005. doi: 10.1056/NEJMoa1014618. - DOI - PMC - PubMed